MannKind founder resigns


MannKind founder Al Mann will continue to have close ties with the company despite his resignation last week from the drug maker's board of directors, CEO Matt Pfeffer said Tuesday. "Al Mann's resignation has caused a lot of concern in some quarters," CEO Matt Pfeffer said on a webcast of the RBC Healthcare conference in New York City.



from Biotech News